Table 1.
Demographics
| Characteristics | HIV– (n = 43) | HIV+ (n = 62) | HIV+ on PI (n = 45) | HIV+ on non-PI (n = 17) |
|---|---|---|---|---|
| Maternal age, y, median (IQR) | 33 (30–36) | 33 (30–37) | 33 (30–36) | 35 (31–38) |
| Maternal prepregnancy BMI, median (IQR) | 24 (21–29) | 24 (21–29) | 25 (22–30) | 24 (20–29) |
| Race | ||||
| Black | 26 (61) | 45 (73) | 35 (78) | 10 (59) |
| White | 14 (33) | 12 (19) | 7 (16) | 5 (29) |
| Other | 3 (7) | 5 (8) | 3 (7) | 2 (12) |
| Delivery mode | ||||
| Vaginal | 28 (65) | 33 (53) | 25 (56) | 8 (47) |
| Scheduled cesarean delivery | 11 (26) | 18 (29) | 11 (24) | 7 (41) |
| Emergency cesarean delivery | 4 (9) | 11 (18) | 9 (20) | 2 (12) |
| Term birth | 43 (100) | 56 (90) | 40 (89) | 16 (94) |
| Preterm birth | 0 (0) | 6 (10) | 5 (11) | 1 (6) |
| Fetal sex | ||||
| Female | 26 (60) | 28 (45) | 21 (47) | 7 (41) |
| Male | 17 (40) | 34 (55) | 24 (53) | 10 (59) |
Data are No. (%) except where indicated.
No significant differences were noted for the HIV-positive group (HIV+) compared to HIV-uninfected (HIV–), or between HIV+ on PI-based ART vs HIV+ on non-PI–based ART, using Mann-Whitney U test or Fisher exact test as appropriate.
Abbreviations: BMI, body mass index; HIV, human immunodeficiency virus; IQR, interquartile range; PI, protease inhibitor.